Abstract
For 58 cases with carcinoma of the prostate, the interrelationship between clinical effect by antiandrogenic treatment with castration and stilbestrols and change of serum acid phosphatase levels were studied and the following results were obtained.1. Pretreatment serum total and prostatic acid phosphatase levels had no significant correlation with five-year survival rate.2. Patients responding with a decrease in the serum acid phosphatase level to the antiandrogenic treatment showed better therapeutic response one year after the start of the treatment and a higher fiveyear survival rate than those who responded with an increase.3. For diagnosis and as an index of treatment in patients with prostatic carcinoma, prostatic serum acid phosphatase was not specific more than total serum acid phosphatase.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
